1
项与 Anti-CD33 CAR-NK cell therapy ( Sichuan Kelun-Biotech Biopharmaceutical) 相关的临床试验Phase I Study to Evaluate the Safety and Effectiveness of Anti-CD33 CAR NK Cell Therapy in Relapsed/Refractory Acute Myeloid Leukemia
CAR technology has been used in T cell therapy and gets great success in treating hematological diseases. Following models of CAR T cells, CAR NK cell therapy has been one hot point. For myeloid malignancies, CD33 is widely expressed. Targeting CD33 surface antigens by CAR NK cells provides an off-the-shelf immune cell therapy.
100 项与 Anti-CD33 CAR-NK cell therapy ( Sichuan Kelun-Biotech Biopharmaceutical) 相关的临床结果
100 项与 Anti-CD33 CAR-NK cell therapy ( Sichuan Kelun-Biotech Biopharmaceutical) 相关的转化医学
100 项与 Anti-CD33 CAR-NK cell therapy ( Sichuan Kelun-Biotech Biopharmaceutical) 相关的专利(医药)
100 项与 Anti-CD33 CAR-NK cell therapy ( Sichuan Kelun-Biotech Biopharmaceutical) 相关的药物交易